These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35106620)

  • 1. Residual effects of zopiclone on driving performance using a standardized driving simulator among healthy volunteers.
    Iwamoto K; Iwata M; Kambe D; Imadera Y; Tachibana N; Kajiyama Y; Ando M; Ozaki N
    Psychopharmacology (Berl); 2022 Mar; 239(3):841-850. PubMed ID: 35106620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a driving simulator for evaluating the residual effects of drugs on driving performance - sensitivity analysis using zopiclone as a positive control: Study Protocol Clinical Trial (SPIRIT Compliant).
    Iwata M; Iwamoto K; Kambe D; Tachibana N; Ando M; Ozaki N
    Medicine (Baltimore); 2020 Mar; 99(12):e19395. PubMed ID: 32195934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Next-day effects of ramelteon (8 mg), zopiclone (7.5 mg), and placebo on highway driving performance, memory functioning, psychomotor performance, and mood in healthy adult subjects.
    Mets MA; de Vries JM; de Senerpont Domis LM; Volkerts ER; Olivier B; Verster JC
    Sleep; 2011 Oct; 34(10):1327-34. PubMed ID: 21966064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On-the-road driving performance the morning after bedtime use of suvorexant 15 and 30 mg in healthy elderly.
    Vermeeren A; Vets E; Vuurman EF; Van Oers AC; Jongen S; Laethem T; Heirman I; Bautmans A; Palcza J; Li X; Troyer MD; Wrishko R; McCrea J; Sun H
    Psychopharmacology (Berl); 2016 Sep; 233(18):3341-51. PubMed ID: 27424295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On-the-road driving performance the morning after bedtime administration of lemborexant in healthy adult and elderly volunteers.
    Vermeeren A; Jongen S; Murphy P; Moline M; Filippov G; Pinner K; Perdomo C; Landry I; Majid O; Van Oers ACM; Van Leeuwen CJ; Ramaekers JG; Vuurman EFPM
    Sleep; 2019 Apr; 42(4):. PubMed ID: 30597112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On-the-Road Driving Performance the Morning after Bedtime Use of Suvorexant 20 and 40 mg: A Study in Non-Elderly Healthy Volunteers.
    Vermeeren A; Sun H; Vuurman EF; Jongen S; Van Leeuwen CJ; Van Oers AC; Palcza J; Li X; Laethem T; Heirman I; Bautmans A; Troyer MD; Wrishko R; McCrea J
    Sleep; 2015 Nov; 38(11):1803-13. PubMed ID: 26039969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zopiclone as positive control in studies examining the residual effects of hypnotic drugs on driving ability.
    Verster JC; Spence DW; Shahid A; Pandi-Perumal SR; Roth T
    Curr Drug Saf; 2011 Sep; 6(4):209-18. PubMed ID: 22129315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highway driving in the elderly the morning after bedtime use of hypnotics: a comparison between temazepam 20 mg, zopiclone 7.5 mg, and placebo.
    Leufkens TR; Vermeeren A
    J Clin Psychopharmacol; 2009 Oct; 29(5):432-8. PubMed ID: 19745642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Residual effects of zopiclone 7.5 mg on highway driving performance in insomnia patients and healthy controls: a placebo controlled crossover study.
    Leufkens TR; Ramaekers JG; de Weerd AW; Riedel WJ; Vermeeren A
    Psychopharmacology (Berl); 2014 Jul; 231(14):2785-98. PubMed ID: 24458443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Residual effects of low-dose sublingual zolpidem on highway driving performance the morning after middle-of-the-night use.
    Vermeeren A; Vuurman EF; Leufkens TR; Van Leeuwen CJ; Van Oers AC; Laska E; Rico S; Steinberg F; Roth T
    Sleep; 2014 Mar; 37(3):489-96. PubMed ID: 24587571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zopiclone's residual effects on actual driving performance in a standardized test: a pooled analysis of age and sex effects in 4 placebo-controlled studies.
    Leufkens TR; Vermeeren A
    Clin Ther; 2014 Jan; 36(1):141-50. PubMed ID: 24360801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential residual effects of zaleplon and zopiclone on actual driving: a comparison with a low dose of alcohol.
    Vermeeren A; Riedel WJ; van Boxtel MP; Darwish M; Paty I; Patat A
    Sleep; 2002 Mar; 25(2):224-31. PubMed ID: 11905433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of acute treatment with ramelteon, triazolam, and placebo on driving performance, cognitive function, and equilibrium function in healthy volunteers.
    Miyata A; Iwamoto K; Kawano N; Kohmura K; Yamamoto M; Aleksic B; Ebe K; Noda A; Noda Y; Iritani S; Ozaki N
    Psychopharmacology (Berl); 2015 Jun; 232(12):2127-37. PubMed ID: 25533998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residual effects of esmirtazapine on actual driving performance: overall findings and an exploratory analysis into the role of CYP2D6 phenotype.
    Ramaekers JG; Conen S; de Kam PJ; Braat S; Peeters P; Theunissen EL; Ivgy-May N
    Psychopharmacology (Berl); 2011 May; 215(2):321-32. PubMed ID: 21246188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highway driving performance and cognitive functioning the morning after bedtime and middle-of-the-night use of gaboxadol, zopiclone and zolpidem.
    Leufkens TR; Lund JS; Vermeeren A
    J Sleep Res; 2009 Dec; 18(4):387-96. PubMed ID: 19552733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Residual effects of hypnotic drugs in aging drivers submitted to simulated accident scenarios: an exploratory study.
    Meskali M; Berthelon C; Marie S; Denise P; Bocca ML
    Psychopharmacology (Berl); 2009 Dec; 207(3):461-7. PubMed ID: 19798483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Residual effect of zolpidem 10 mg and zopiclone 7.5 mg versus flunitrazepam 1 mg and placebo on driving performance and ocular saccades.
    Bocca ML; Le Doze F; Etard O; Pottier M; L'Hoste J; Denise P
    Psychopharmacology (Berl); 1999 Apr; 143(4):373-9. PubMed ID: 10367554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-bedtime dosing with indiplon in adults and the elderly: results from two placebo-controlled, active comparator crossover studies in healthy volunteers.
    Farber RH; Burke PJ
    Curr Med Res Opin; 2008 Mar; 24(3):837-46. PubMed ID: 18257978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validity and reliability of a driving simulator for evaluating the influence of medicinal drugs on driving performance.
    Iwata M; Iwamoto K; Kitajima I; Nogi T; Onishi K; Kajiyama Y; Nishino I; Ando M; Ozaki N
    Psychopharmacology (Berl); 2021 Mar; 238(3):775-786. PubMed ID: 33236169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lapses of attention as outcome measure of the on-the-road driving test.
    Verster JC; Bervoets AC; de Klerk S; Roth T
    Psychopharmacology (Berl); 2014 Jan; 231(1):283-92. PubMed ID: 23975036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.